Skip to Navigation
Company
Home
  • Company

An outpost of global open innovation, JW Theriac

Strengthening networks with global bio clusters based on JW's R&D technology,
Innovative new drug pipeline expansion

  • Establishment of a global bio cluster network

    Established in 2001, JW Theriac is a specialized research subsidiary of JW Pharmaceutical and is located in Boston, USA.

    JW Group, a comprehensive healthcare company, includes JW Pharmaceutical Drug Discovery Center, C&C Research Laboratories, and JW Bioscience.
    We are conducting R&D equipped with specialized research facilities in each field Oncology, Immunology, Regenerative Medicine .

  • Expansion of innovative new drug pipeline using
    JW R&D platform

    JW Theriac focuses on global open innovation activities, creating a new platform that can create synergy with JW's pipeline.
    We are preparing research collaboration and cooperation plans with target-oriented innovative companies.
    Based on over 20 years of know-how and experience, we are leading cooperation on innovative new drug development programs.